Immunopathogenesis of inflammatory bowel disease: current concepts

Area of Science:

• Immunology
• Gastroenterology
• Genetics

Background:

• Current understanding attributes inflammatory bowel disease (IBD) to immune dysregulation against gut bacteria in genetically susceptible individuals.
• Emerging evidence supports alternative hypotheses for IBD pathogenesis.
• This review explores novel immunogenetic pathways influencing IBD development.

Purpose of the Study:

• To present novel immunogenetic pathways involved in inflammatory bowel disease.
• To discuss the impact of these pathways on the traditional understanding of IBD pathogenesis.
• To highlight recent findings that are reshaping IBD research.

Main Methods:

• Review of recent scientific literature and data.
• Analysis of immunogenetic pathways.
• Discussion of innate and adaptive immune system roles in IBD.

Main Results:

• The innate immune system's failure to contain intraluminal bacteria locally appears central to IBD.
• Impairment of NOD2 signaling or other deficiencies may underlie this innate immune defect.
• The traditional Th1/Th2 differentiation model for Crohn's disease and ulcerative colitis is evolving, with the interleukin-23/Th17 axis emerging as a key pathway in tissue injury.

Conclusions:

• Understanding the specific pathways of chronic intestinal inflammation is crucial for IBD treatment.
• Elucidation of these pathways will enable the development of more targeted and less toxic therapies for IBD.
• Future research directions focus on novel effector pathways and immunogenetic targets.